Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-06
1997-08-05
Haley, Jacqueline
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548492, 548494, 548495, 544373, 514381, C07D40312, C07D20912, A61K 31495, A61K 31405
Patent
active
056543263
ABSTRACT:
A class of novel 1H-indole-3-glyoxylamides is disclosed together with the use of such indole compounds for inhibiting sPLA.sub.2 mediated release of fatty acids for treatment of conditions such as septic shock.
REFERENCES:
patent: 2825734 (1958-03-01), Speeter
patent: 3242163 (1966-03-01), Sarett et al.
patent: 3259622 (1966-07-01), Shen et al.
patent: 3351630 (1967-11-01), Shen
patent: 3449363 (1969-06-01), Littell
patent: 3624103 (1971-11-01), DeMartilis et al.
patent: 3691194 (1972-09-01), Papanastassion
patent: 3801594 (1974-04-01), Poletto
patent: 4012513 (1977-03-01), Birchall et al.
patent: 4397850 (1983-08-01), Madelson
Jula, Marc; Igolen, Jean; and Igolen, Hanne; "Recherches en serie indolique. VI Sur quelques tryptamines substitutes"; Bul. Soc. Chem. France, 1962, pp. 1060-1068.
Romeo, E., "2-Aryl-3-Indoleglyoxylamides (FGIN-1): A New Class of Potent and Specific Ligands for the Mitochondrial DBI Receptor (MDR)", The Journal of Pharmacology and Experimental Therapeutics, vol. 262, No. 3, pp. 971-78 1992.
Chemical Abstracts, vol. 67, 73028h, 1967, "Fragmentation of N-benzylindoles in Mass Spectrometry".
Alemany, A; Alvarez, E.; Lopez, O. and Herraez, M.E.; No. 565 --"Inhibiteurs d'enzymes. XII --Prepartion de (propargyamino-2-ethyl)-3-indoles"; Bulletin Do La Societe 'Chimiqque De France, 1974, No. 12, pp. 2883-2888.
Kollenz, Gert; Labes, Christa: "Indol-Umlagerung von 1-Diphenyl amino-2,3-dihydro-2,3-pyrrolidionen"; Liebigs Ann. Chem., 1975, pp. 1979-1983.
Kreft, A; Nelson, J. et al.; "Structure-activity relationships leadikng to WAY-121,520, a tris aryl type, Nidomethacin-based, phospholipase A2 (PLA2)/leukotriene biosynthesis inhibitor", Issue vol. 39 (1993), pp. C33-C35, ISSN 0065-4299; publ. by Birkhauser Verlag, Basel Switzerland; (Proceedings of the Sixth International Research Assoc., Sep. 20-24, 1992 at White Haven, PA/USA, Ed., D.W. Morgan and A.K. Welton.
Seilhamer, Jeffery, et al., "Cloning and Recombinant Expression of Phospholipase A.sub.2 present in Rheumatoid Arthritic Synovial Fluid"; The Journal of Biological Chemistry, 254:10, Apr. 5, 1989, pp. 5335-5338.
Kramer, Ruther et al., "Structure and Properties of a Human Non-Pancreatic Phospholipase A.sub.2 ", The Journal of Biological Chemistry, 264:10, Apr. 5, 1989, pp. 5768-5775.
Reynolds, et al., "Analysis of Human Synovial Fluid Phospholipase A2 on Short Chain Phosphatidylcholine-Mixed Micelles: Development of a Spectrophotometric Assay Suitable for a Microtiterplate Reader", Analytical Biochem, 204, pp. 190-197, 1992.
Rossum, et al., "Cimulative Dose-Response Curves II. Technique for the making of dose response curves in isolated organs and the evaluation of drug parameters", Arch. Int. Pharmacodyn. 143, No. 3-4, pp. 299-330, 1963.
Wald, Douglas R., "Analysis of Dose-Response Relationships", Dept. of Pharma., Univ. of Mass. Med. Center, 145-179 (no date available).
Andreani, A. et al., "Nonsteroidal Antiinflammatory Agents. 2. Synthesis and Biological Activity of 2 --Chlorindolecarboxylic Acids"; Journal of Medicinal Chemistry, vol. 20, No. 10, 1977, pp. 1344-1346.
Julia, Marc, et al., "No. 208 --Recherches en serie indolique. XIII. Sur quelques methoxy -5 et.-6 tryptamines", Bulletin de La Societe Chimique de France, Paris, France; 1965, pp. 1411-1417.
Chemical Abstracts, vol. 1/2. No. 24, Abstract No. 223181s; "Kinetics of hydrolysis of indomethacin and indomethacin ester predrigs in aqueous solution" Jun. 11, 1990, p. 407.
Chemical Abstracts Service, "Registry Handbook", Number Section, Registry Numbers (see, CAS RN 6264-33-1) 1965-1971, Publ. American Chemical Society.
Von K. H. Boltze; O. Brendler, et al., "Chemische Struktur und antiphlogistische Wirkung in der Reihe der substituierten Indol-3-essigsauren", Arznermittel Forschung Drug Research, vol. 30 (II), No. 8A, 1980, Aulendorf, DE, pp. 1314-1325.
Bach Nicholas J.
Dillard Robert D.
Draheim Susan E.
Benjamin Roger S.
Boone David E.
Eli Lilly and Company
Haley Jacqueline
LandOfFree
1H-indole-3-glyoxylamide SPLA.sub.2 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1H-indole-3-glyoxylamide SPLA.sub.2 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1H-indole-3-glyoxylamide SPLA.sub.2 inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1075169